By vgreene, 20 July, 2020 If person suspected to have post-infectious syndrome (eg, MIS-C) caused by SARS-CoV-2 infection, serologic assays may be used
By vgreene, 20 July, 2020 In certain situations, serologic assays may be used to support clinical assessment of persons who present late in illnesses (in conjunction w/ viral detection tests)
By vgreene, 20 July, 2020 CDC does not currently recommend using antibody testing as sole basis for dx of acute infxn; antibody tests are not authorized by FDA for such diagnostic purposes
By vgreene, 20 July, 2020 Antibody tests help determine whether individual was previously infected—even if that person never showed sx
By vgreene, 20 July, 2020 For more info on testing, see Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens and Biosafety FAQs